Tag : Blood Cancer

Latest News

Novel CAR T-cell therapy shows promising early results in children with neuroblastoma

Newsemia
A novel CAR T-cell therapy developed by researchers at UCL and designed to target cancerous tumors, has shown promising early results in children with neuroblastoma,...
Latest News

New partnership aims to advance predictive tests for multiple myeloma in Ireland

Newsemia
By combining genomic testing and next generation sequencing technology, a new partnership led by RCSI researchers aims to advance predictive tests for multiple myeloma, the...
Latest News

Researchers discover physiological mechanisms underlying pediatric B-ALL

Newsemia
B-cell acute lymphoblastic leukemia (B-ALL) is characterized by the accumulation of abnormal immature B-cell precursors in the bone marrow and is the most common pediatric...
Latest News

Artificial intelligence can detect AML with high reliability

Newsemia
Artificial intelligence can detect one of the most common forms of blood cancer – acute myeloid leukemia (AML) – with high reliability. Source link...
Gastroenterology

Researchers discover a way to move precision immunotherapy forward for multiple myeloma

Newsemia
Researchers at the Icahn School of Medicine at Mount Sinai have discovered a way to move precision immunotherapy forward by using genomics to inform immunotherapy...
Latest News

Exposure to 9/11 WTC dust associated with increased risk of heart disease in NYC firefighters

Newsemia
A new study of New York City firefighters has found that exposure to 9/11 World Trade Center dust is associated with a significantly increased long-term...
Latest News

Study discovers new therapy for aggressive blood cancer

Newsemia
Acute myeloid leukemia is the most common form of acute leukemia. It is characterized by an increase of malignant myeloid progenitor cells at the expense...
Latest News

Phase III CLL14 study evaluating Venclexta plus Gazyva to treat CLL meets its primary endpoint

Newsemia
Genentech, a member of the Roche Group , announced today that the randomized Phase III CLL14 study, which evaluated fixed-duration Venclexta® in combination with Gazyva®...
Latest News

Ten Allen Distinguished Investigators for 2018 announced by Paul G. Allen Frontiers Group

Newsemia
Nanoparticles that could reprogram a cancer patient’s immune system inside their own body. Understanding a mysterious type of brain cell in the hopes of shedding...
Latest News

Researchers develop promising targeted strategy to treat chemo-resistant blood cancer

Newsemia
Researchers from The Ottawa Hospital and the University of Ottawa have developed a promising targeted strategy to treat chemotherapy-resistant acute myeloid leukemia and a diagnostic...
Latest News

Researchers identify new cancerous cells responsible for acute myeloid leukemia relapse

Newsemia
McMaster University researchers have provided evidence of new cancerous cells they have termed cancer regenerating cells, which are responsible for the return of acute myeloid...
Gastroenterology

RNA and DNA sequencing platform matches broader swath of drugs to late-stage cancer patients

Newsemia
A comprehensive RNA and DNA sequencing platform benefits late-stage and drug-resistant multiple myeloma patients by determining which drugs would work best for them, according to...
Latest News

Research uncovers new approach for expanding stem cells from umbilical cord blood

Newsemia
Researchers from the Stowers Institute for Medical Research and collaborators have identified a way to expand blood-forming, adult stem cells from human umbilical cord blood....

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy